GRCh38 · COSMIC v99


This section shows a general overview of the selected mutation. It describes the source of the mutation i.e gene name/sample name/tissue name with unique ID, and also shows the mutation syntax at the amino acid and nucleotide sequence level. You can see more information on our help pages.

Genomic Mutation ID
Genomic mutation identifier (COSV) to indicate the definitive position of the variant on the genome. This identifier is trackable and stable between different versions of the release. Also, this identifier remains the same between different assemblies (GRCh37 and GRCh38).
Legacy Identifier
Legacy mutation identifier (COSM) represents existing COSM mutation identifiers. This identifier remains the same between different assemblies (GRCh37 and GRCh38). All the COSM ids at the same genomic location have been collapsed into one representative COSM id. These ids are maintained to help track existing mutations.
Gene name
AA mutation
p.? (Unknown)
CDS mutation
c.*527T>G (Substitution)
Nucleotides inserted
Genomic coordinates
GRCh38, 22:21763723..21763723, view Ensembl contig
Ever confirmed somatic?
Drug resistance
Alternative Ids
These are internal identifiers that are unique to a mutation on a particular transcript and are displayed in the URL of the mutation pages. Therefore, several of these internal ids could be associated with a single genomic COSV id where the mutation has been mapped to all overlapping genes and transcripts. Similarly, since every COSM id is mapped to one COSV id (where genomic coordinates are known), each COSM id can also be associated with several alternative (internal) identifiers. These ids are expected to change between assemblies (GRCh37 and GRCh38) and between the releases.

Tissue distribution

This section displays the distribution of mutated samples and tissue types (top 5). You can see more information on our help pages.


This section displays a table of mutated samples, with tissue, histology and zygosity information. Publication information is also included, where available, with links to PUBMED.

Sample name Gene name Transcript Primary Tissue Tissue Subtype 1 Primary Histology Histology Subtype 1 Pubmed ID Zygosity Somatic Status Sample Type LOH Resistant Mutation Drugs

Pathways affected

This section shows pathways affected by this mutation.

Source Pathways
WikiPathway IL-5 Signaling Pathway
WikiPathway Androgen Receptor Signaling Pathway
WikiPathway Osteopontin
WikiPathway Type II diabetes mellitus
WikiPathway Regulation of toll-like receptor signaling pathway
WikiPathway Physiological + Pathological hypertrophy (Heart)
WikiPathway Angiogenesis
WikiPathway MicroRNAs in cardiomyocyte hypertrophy
WikiPathway Heart Development
WikiPathway Integrin-mediated cell adhesion
WikiPathway IL-7 Signaling Pathway
WikiPathway IL-9 Signaling Pathway
WikiPathway B Cell Receptor Signaling Pathway
WikiPathway Nifedipine
WikiPathway Signal Transduction of S1P Receptor
WikiPathway IL-3 Signaling Pathway
WikiPathway EBV LMP1 signaling
WikiPathway Kit Receptor Signaling Pathway
WikiPathway Focal Adhesion
WikiPathway Signaling of Hepatocyte Growth Factor Receptor
WikiPathway MAPK signaling pathway
WikiPathway Wnt Signaling Pathway NetPath
WikiPathway IL-6 Signaling Pathway
WikiPathway IL-4 signaling Pathway
WikiPathway MAPK Cascade
WikiPathway EGFR1 Signaling Pathway
WikiPathway Regulation of Actin Cytoskeleton
WikiPathway Insulin Signaling
WikiPathway IL-2 Signaling Pathway
WikiPathway ACE Inhibitor Pathway
WikiPathway Delta-Notch Signaling Pathway
WikiPathway Senescence and Autophagy
WikiPathway EPO Receptor Signaling
WikiPathway estrogen signalling
WikiPathway Toll-like receptor signaling pathway
WikiPathway Hypothetical Network for Drug Addiction
WikiPathway ErbB signaling pathway
WikiPathway T Cell Receptor Signaling Pathway
WikiPathway DNA damage response (only ATM dependent)


This section displays a table of references for the mutation. You can see more information on the help pages.

Reference Title Author Year Journal Status COSMIC Pubmed